Jiangsu Yangnong Chemical (600486) H2 2025 earnings summary

Executive summary

• Achieved revenue of ¥11.87 billion in 2025, up 13.76% year-over-year, with net profit attributable to shareholders of ¥1.29 billion, up 6.98% year-over-year.

• Domestic sales reached ¥4.85 billion (+11.55%), international sales ¥6.81 billion (+15.02%).

• Maintained strong market position in pyrethroid and herbicide segments, with significant R&D and production capacity expansion.

• Proposed cash dividend of ¥7.14 per 10 shares, total cash dividend payout ratio at 30.07% of net profit.

Financial highlights

• Operating income: ¥11.87 billion (+13.76% YoY); net profit: ¥1.29 billion (+6.98% YoY).

• Operating cash flow: ¥2.22 billion (+2.85% YoY).

• Gross margin for main business: 22.18%, down 1.26 percentage points YoY.

• Basic EPS: ¥3.188 (+7.04% YoY); ROE: 11.69%.

• R&D expense: ¥392.87 million, 3.31% of revenue.

Outlook and guidance

• 2026 focus on strengthening domestic and international integration, cost control, and innovation.

• Plans to accelerate new product commercialization, enhance supply chain resilience, and continue green transformation.

• Industry expected to benefit from policy support for food security and green agriculture, but faces ongoing global economic and geopolitical uncertainties.